Search company, investor...

BioImagene

bioimagene.com

Founded Year

2003

Stage

Acquired | Acquired

Total Raised

$42.2M

Valuation

$0000 

About BioImagene

BioImagene is a provider of image informatics solutions for digital pathology, covering a wide range of products from Discovery to Diagnostics. All products are for research use only except Pathiam Imaging Software for HER2/neu. The company was founded in 2003 and is based in Sunnyvale, California.

Headquarters Location

919 Hermosa Court

Sunnyvale, California, 94085,

United States

408-207-4200

Missing: BioImagene's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: BioImagene's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

BioImagene Patents

BioImagene has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/23/2006

7/20/2010

G protein coupled receptors, Transcription factors, Image processing, Rare diseases, Clusters of differentiation

Grant

Application Date

2/23/2006

Grant Date

7/20/2010

Title

Related Topics

G protein coupled receptors, Transcription factors, Image processing, Rare diseases, Clusters of differentiation

Status

Grant

Latest BioImagene News

BioImagene Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

Nov 28, 2016

BioImagene, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 00:24 EST 28 Nov 2016 | BioPortfolio Reports Home » Topics » Biotechnology Business » Latest News » BioImagene, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' BioImagene, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by BioImagene, Inc. since January 2007. Key Findings Provides intelligence on BioImagene, Inc. MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by BioImagene, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for BioImagene, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about BioImagene, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News

BioImagene Frequently Asked Questions (FAQ)

  • When was BioImagene founded?

    BioImagene was founded in 2003.

  • Where is BioImagene's headquarters?

    BioImagene's headquarters is located at 919 Hermosa Court, Sunnyvale.

  • What is BioImagene's latest funding round?

    BioImagene's latest funding round is Acquired.

  • How much did BioImagene raise?

    BioImagene raised a total of $42.2M.

  • Who are the investors of BioImagene?

    Investors of BioImagene include Roche Holding, ICCP Venture Partners, Hawaii Angels, Ascension Ventures, Artiman Ventures and 8 more.

  • Who are BioImagene's competitors?

    Competitors of BioImagene include Huron Digital Pathology, Magellan Biosciences, Applied Spectral Imaging, AngioLogix, BioFX Laboratories and 12 more.

Compare BioImagene to Competitors

G
Gendex Corporation

Engages in the research and development, production and distribution of imaging equipment for the dental market. Gendex offers radiology and imaging products, including panoramic x-ray, intraoral x-ray, digital imaging, cameras and software.

K
Kjaya

Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.

Symetrica Logo
Symetrica

Symetrica offers gamma ray spectroscopy and imaging solutions. The company's systems have been developed for security applications, medical diagnostics, geophysical applications, and space research and development.

I
Imorphics Limited

Imorphics is a spin-out from the Division of Imaging Science and Biomedical Engineering in the Faculty of Medicine and is based on more than 20 year's research led by Professor Chris Taylor. The company sells 3D medical image analysis software which is being used to improve the speed and accuracy of measurements taken in drug trials. MTF introduced Chairman Mike Bowes to the company. Mike Bowes was previously CEO of Kestra, an imaging start-up backed by 3i which was sold in 1999.

N
NovaRay Medical

NovaRay Medical, Inc. was founded to develop and commercialize a revolutionary digital x-ray technology for medical imaging.

R
Real-time Radiography

Real-Time Radiography is developing the direct Digital Radiography (DR) detectors based on its mercuric iodide x-ray photoconductor technology.nThe detector's exceptional sensitivity to x-rays, cost advantages, and low-voltage operation allow it to provide high image quality at low doses of radiation and at reduced expense to the end user. RTR is focused on bringing to market the digital x-ray imaging technology for medical, industrial, and security applications.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.